171 related articles for article (PubMed ID: 34166428)
1. Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda.
Piloya TW; Bakeera-Kitaka S; Kisitu GP; Idro R; Cusick SE
PLoS One; 2021; 16(6):e0253689. PubMed ID: 34166428
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy.
Crutchley RD; Jacobs DM; Gathe J; Mayberry C; Bulayeva N; Rosenblatt KP; Garey KW
Curr HIV Res; 2021; 19(1):61-72. PubMed ID: 32860360
[TBL] [Abstract][Full Text] [Related]
3. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
[TBL] [Abstract][Full Text] [Related]
4. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
Coelho L; Cardoso SW; Luz PM; Hoffman RM; Mendonça L; Veloso VG; Currier JS; Grinsztejn B; Lake JE
Nutr J; 2015 Aug; 14():81. PubMed ID: 26283663
[TBL] [Abstract][Full Text] [Related]
6. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.
Kekitiinwa A; Lee KJ; Walker AS; Maganda A; Doerholt K; Kitaka SB; Asiimwe A; Judd A; Musoke P; Gibb DM; ;
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):384-92. PubMed ID: 18931630
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
Poowuttikul P; Thomas R; Hart B; Secord E
J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
[TBL] [Abstract][Full Text] [Related]
8. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.
Musarurwa C; Zijenah LS; Mhandire DZ; Bandason T; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
BMC Pulm Med; 2018 May; 18(1):67. PubMed ID: 29739378
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status, nutrition and growth in HIV-infected mothers and HIV-exposed infants and children in Botswana.
Tindall AM; Schall JI; Seme B; Ratshaa B; Tolle M; Nnyepi MS; Mazhani L; Rutstein RM; Steenhoff AP; Stallings VA
PLoS One; 2020; 15(8):e0236510. PubMed ID: 32790765
[TBL] [Abstract][Full Text] [Related]
10. The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults.
Eckard AR; Tangpricha V; Seydafkan S; O'Riordan MA; Storer N; Labbato D; McComsey GA
Pediatr Infect Dis J; 2013 Nov; 32(11):1224-9. PubMed ID: 23360833
[TBL] [Abstract][Full Text] [Related]
11. Effect of Vitamin D Supplementation on CD4 Count in HIV-Infected Children and Adolescents in North India: A Non-Randomized Comparative Study.
Verma P; Shrivastava A; Siddiqui SA; Yadav RK; Singh MV; Tripathi A; Maurya M; Mishra N
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 35944184
[TBL] [Abstract][Full Text] [Related]
12. Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.
Cervero M; Agud JL; Torres R; García-Lacalle C; Alcázar V; Jusdado JJ; Moreno S
HIV Med; 2013 Oct; 14(9):556-62. PubMed ID: 23738846
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting.
Wiboonchutikul S; Sungkanuparph S; Kiertiburanakul S; Chailurkit LO; Charoenyingwattana A; Wangsomboonsiri W; Chantratita W; Ongphiphadhanakul B
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):305-10. PubMed ID: 22247338
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy.
Aurpibul L; Sricharoenchai S; Wittawatmongkol O; Sirisanthana V; Phongsamart W; Sudjaritruk T; Chokephaibulkit K
J Pediatr Endocrinol Metab; 2016 Apr; 29(4):407-11. PubMed ID: 26565540
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency among adult patients with tuberculosis: a cross sectional study from a national referral hospital in Uganda.
Kibirige D; Mutebi E; Ssekitoleko R; Worodria W; Mayanja-Kizza H
BMC Res Notes; 2013 Jul; 6():293. PubMed ID: 23886009
[TBL] [Abstract][Full Text] [Related]
17. Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir.
Chokephaibulkit K; Nuntarukchaikul M; Phongsamart W; Wittawatmongkol O; Lapphra K; Vanprapar N; Cressey TR
J Antimicrob Chemother; 2012 Dec; 67(12):2927-31. PubMed ID: 22923483
[TBL] [Abstract][Full Text] [Related]
18. Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study.
Resino S; Bellón JM; Ramos JT; Gonzalez-Rivera M; de José MI; González MI; Gurbindo D; Mellado MJ; Cabrero E; Muñoz-Fernández MA
J Antimicrob Chemother; 2004 Nov; 54(5):921-31. PubMed ID: 15472006
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
Achan J; Kakuru A; Ikilezi G; Ruel T; Clark TD; Nsanzabana C; Charlebois E; Aweeka F; Dorsey G; Rosenthal PJ; Havlir D; Kamya MR
N Engl J Med; 2012 Nov; 367(22):2110-8. PubMed ID: 23190222
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients.
Theodorou M; Sersté T; Van Gossum M; Dewit S
Clin Nutr; 2014 Apr; 33(2):274-9. PubMed ID: 23680190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
